Xeris Pharmaceuticals - Latest Emails, Sales & DealsXeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)October 4, 2024 - 9 days agoXeris to Participate in Upcoming Investor ConferencesAugust 22, 2024 - 1 month agoNew Form 4 for Xeris Pharmaceuticals, Inc.August 13, 2024 - 2 months agoNew Form 4 for Xeris Pharmaceuticals, Inc.August 12, 2024 - 2 months agoNew Form 4 for Xeris Pharmaceuticals, Inc.August 9, 2024 - 2 months agoNew Form 4 for Xeris Pharmaceuticals, Inc.August 9, 2024 - 2 months agoNew Form 4 for Xeris Pharmaceuticals, Inc.August 9, 2024 - 2 months agoNew Form S-8 for Xeris Pharmaceuticals, Inc.August 8, 2024 - 2 months agoNew Form 10-Q for Xeris Pharmaceuticals, Inc.August 8, 2024 - 2 months agoNew Form 8-K for Xeris Pharmaceuticals, Inc.August 8, 2024 - 2 months agoXeris Biopharma Reports Second Quarter 2024 Financial ResultsAugust 8, 2024 - 2 months agoNew Form 8-K for Xeris Pharmaceuticals, Inc.August 3, 2024 - 2 months agoNew Form 4 for Xeris Pharmaceuticals, Inc.August 3, 2024 - 2 months agoNew Form 4 for Xeris Pharmaceuticals, Inc.August 3, 2024 - 2 months agoNew Form 3 for Xeris Pharmaceuticals, Inc.August 3, 2024 - 2 months agoXeris Biopharma to Report Second Quarter 2024 Financial Results on August 8, 2024July 25, 2024 - 2 months agoNew Form 8-K for Xeris Pharmaceuticals, Inc.July 8, 2024 - 3 months agoXeris Biopharma Announces CEO Succession PlanJuly 8, 2024 - 3 months agoXeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)July 3, 2024 - 3 months agoNew Form 4 for Xeris Pharmaceuticals, Inc.June 5, 2024 - 4 months agoNew Form 4 for Xeris Pharmaceuticals, Inc.June 5, 2024 - 4 months agoNew Form 4 for Xeris Pharmaceuticals, Inc.June 5, 2024 - 4 months agoNew Form 4 for Xeris Pharmaceuticals, Inc.June 5, 2024 - 4 months agoNew Form 4 for Xeris Pharmaceuticals, Inc.June 5, 2024 - 4 months agoNew Form 4 for Xeris Pharmaceuticals, Inc.June 5, 2024 - 4 months agoNew Form 4 for Xeris Pharmaceuticals, Inc.June 5, 2024 - 4 months agoNew Form 4 for Xeris Pharmaceuticals, Inc.June 5, 2024 - 4 months agoNew Form 8-K for Xeris Pharmaceuticals, Inc.June 5, 2024 - 4 months agoXeris Presents New Post Hoc Analysis on Effects of Levoketoconazole (Recorlev®) in Cushing’s Syndrome Patients at ENDO 2024June 3, 2024 - 4 months agoXeris Biopharma Announces Positive Topline Phase 2 Clinical Data of Its Investigational XeriSol™-Formulated Once-Weekly Subcutaneous (SC) Levothyroxine (XP-8121)May 30, 2024 - 4 months agoXeris to Participate in the Jefferies Global Healthcare ConferenceMay 30, 2024 - 4 months agoNew Form 4 for Xeris Pharmaceuticals, Inc.May 10, 2024 - 5 months agoNew Form 10-Q for Xeris Pharmaceuticals, Inc.May 9, 2024 - 5 months agoNew Form 8-K for Xeris Pharmaceuticals, Inc.May 9, 2024 - 5 months agoXeris Biopharma Reports First Quarter 2024 Financial Results and Recent EventsMay 9, 2024 - 5 months agoXeris Enters Into an Exclusive Worldwide Collaboration and License Agreement with Beta BionicsMay 6, 2024 - 5 months agoXeris Biopharma to Report First Quarter 2024 Financial Results on May 9, 2024May 3, 2024 - 5 months agoNew Form ARS for Xeris Pharmaceuticals, Inc.April 23, 2024 - 5 months agoNew Form DEFA14A for Xeris Pharmaceuticals, Inc.April 23, 2024 - 5 months agoNew Form DEF 14A for Xeris Pharmaceuticals, Inc.April 23, 2024 - 5 months agoNew Form 4 for Xeris Pharmaceuticals, Inc.April 11, 2024 - 6 months agoXeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)April 3, 2024 - 6 months agoXeris Biopharma to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceApril 2, 2024 - 6 months agoNew Form 4 for Xeris Pharmaceuticals, Inc.April 1, 2024 - 6 months agoNew Form 4 for Xeris Pharmaceuticals, Inc.April 1, 2024 - 6 months agoNew Form 4 for Xeris Pharmaceuticals, Inc.March 18, 2024 - 6 months agoNew Form 4 for Xeris Pharmaceuticals, Inc.March 15, 2024 - 7 months agoNew Form S-8 for Xeris Pharmaceuticals, Inc.March 6, 2024 - 7 months agoNew Form 10-K for Xeris Pharmaceuticals, Inc.March 6, 2024 - 7 months agoNew Form 8-K for Xeris Pharmaceuticals, Inc.March 6, 2024 - 7 months agoXeris Refinances Its $150M Senior Secured Term Loan Facility With Hayfin CapitalMarch 6, 2024 - 7 months agoXeris Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent EventsMarch 6, 2024 - 7 months agoXeris Biopharma to Report Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024February 28, 2024 - 7 months agoNew Form SC 13G for Xeris Pharmaceuticals, Inc.February 13, 2024 - 8 months agoNew Form SC 13G/A for Xeris Pharmaceuticals, Inc.February 13, 2024 - 8 months agoXeris to Present at the Oppenheimer 34th Annual Healthcare Life Science ConferenceFebruary 5, 2024 - 8 months agoNew Form 4 for Xeris Pharmaceuticals, Inc.January 31, 2024 - 8 months agoNew Form 4 for Xeris Pharmaceuticals, Inc.January 31, 2024 - 8 months agoNew Form 4 for Xeris Pharmaceuticals, Inc.January 31, 2024 - 8 months agoNew Form 4 for Xeris Pharmaceuticals, Inc.January 31, 2024 - 8 months agoNew Form 4 for Xeris Pharmaceuticals, Inc.January 31, 2024 - 8 months agoNew Form SC 13G for Xeris Pharmaceuticals, Inc.January 26, 2024 - 8 months agoXeris Biopharma Enters Into an Exclusive Worldwide License Agreement for Xeriject® Formulation of TeprotumumabJanuary 10, 2024 - 9 months agoXeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)January 5, 2024 - 9 months agoNew Form 8-K for Xeris Pharmaceuticals, Inc.January 4, 2024 - 9 months agoXeris Biopharma Updates Its Outlook for 2023January 4, 2024 - 9 months agoXeris Biopharma to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceDecember 27, 2023 - 9 months agoNew Form 4 for Xeris Pharmaceuticals, Inc.December 1, 2023 - 10 months agoNew Form 4 for Xeris Pharmaceuticals, Inc.November 29, 2023 - 10 months agoNew Form 4 for Xeris Pharmaceuticals, Inc.November 21, 2023 - 10 months agoNew Form 4 for Xeris Pharmaceuticals, Inc.November 21, 2023 - 10 months agoNew Form 4 for Xeris Pharmaceuticals, Inc.November 17, 2023 - 11 months agoNew Form 4 for Xeris Pharmaceuticals, Inc.November 17, 2023 - 11 months agoNew Form 4 for Xeris Pharmaceuticals, Inc.November 15, 2023 - 11 months agoNew Form 10-Q for Xeris Pharmaceuticals, Inc.November 9, 2023 - 11 months agoNew Form 8-K for Xeris Pharmaceuticals, Inc.November 9, 2023 - 11 months agoXeris Biopharma Reports Third Quarter 2023 Financial ResultsNovember 9, 2023 - 11 months agoNew Form 8-K for Xeris Pharmaceuticals, Inc.October 16, 2023 - 12 months agoXeris Biopharma Raises Full-Year Financial Guidance and Reaffirms Cash Flow Breakeven in Q4 2023October 16, 2023 - 12 months agoNew Form 8-K for Xeris Pharmaceuticals, Inc.September 29, 2023 - 12 months agoNew Form 8-K for Xeris Pharmaceuticals, Inc.September 27, 2023 - 12 months agoXeris Biopharma Announces Private Convertible Note Exchange TransactionsSeptember 27, 2023 - 12 months agoXeris to Participate in the 2023 Cantor Global Healthcare ConferenceSeptember 14, 2023 - 13 months agoXeris to Participate at the H.C. Wainwright 25th Annual Global Investment ConferenceAugust 28, 2023 - 13 months agoNew Form 4 for Xeris Pharmaceuticals, Inc.August 9, 2023 - 14 months agoNew Form 10-Q for Xeris Pharmaceuticals, Inc.August 8, 2023 - 14 months agoNew Form 8-K for Xeris Pharmaceuticals, Inc.August 8, 2023 - 14 months agoXeris Biopharma Reports Second Quarter 2023 Financial ResultsAugust 8, 2023 - 14 months agoXeris Biopharma to Report Second Quarter 2023 Financial Results on August 8, 2023August 1, 2023 - 14 months agoXeris Ships One Millionth Gvoke® UnitJuly 31, 2023 - 14 months ago12LatestFind More Emails, Deals & Sales From These StoresPetit LemPiagetKC Cattle CompanyAmericanHortFW BeautyBiomel LifeThird LoveMainspring BoutiqueDarc SportApollo ModaDoyouevenTNW DealsHood Canal BridgeJezebelWellness.comUniversal StandardSports DirectAtom RetroNoni BWhistler Blackcomb